Skip to main content
Premium Trial:

Request an Annual Quote

Maybe They Should Look into Those "Self-Starters" on Craigslist

Ready to dole out some of its taxpayer-funded $3 billion, the California Institute for Regenerative Medicine is still looking to fill the president's position, according to this report in Wired. Seven months into the search, directors of the embryonic stem-cell research program have met privately to discuss boosting the salary range beyond its current cap of $412,500. Some wonder if it's the management structure or Chairman Robert Klein's management style that's scaring potential candidates away.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.